161 related articles for article (PubMed ID: 37190556)
21. Comparative study of macular ganglion cell-inner plexiform layer and peripapillary retinal nerve fiber layer measurement: structure-function analysis.
Shin HY; Park HY; Jung KI; Park CK
Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7344-53. PubMed ID: 24130187
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of Retinal Layer Thickness Parameters as Biomarkers in a Real-World Multiple Sclerosis Cohort.
Schurz N; Sariaslani L; Altmann P; Leutmezer F; Mitsch C; Pemp B; Rommer P; Zrzavy T; Berger T; Bsteh G
Eye Brain; 2021; 13():59-69. PubMed ID: 33737853
[TBL] [Abstract][Full Text] [Related]
23. Retina ganglion cell/inner plexiform layer and peripapillary nerve fiber layer thickness in patients with acromegaly.
Şahin M; Şahin A; Kılınç F; Yüksel H; Özkurt ZG; Türkcü FM; Pekkolay Z; Soylu H; Çaça İ
Int Ophthalmol; 2017 Jun; 37(3):591-598. PubMed ID: 27492731
[TBL] [Abstract][Full Text] [Related]
24. Use of retinal optical coherence tomography to differentiate suspected neuromyelitis optica spectrum disorder from multiple sclerosis: A cross-sectional study.
Ayoubi NKE; Moussa H; Younes A; Haddad R; Khoury SJ
Mult Scler Relat Disord; 2022 Dec; 68():104160. PubMed ID: 36113276
[TBL] [Abstract][Full Text] [Related]
25. Retinal layer thinning predicts treatment failure in relapsing multiple sclerosis.
Bsteh G; Hegen H; Altmann P; Auer M; Berek K; Di Pauli F; Leutmezer F; Rommer P; Wurth S; Zinganell A; Zrzavy T; Deisenhammer F; Berger T
Eur J Neurol; 2021 Jun; 28(6):2037-2045. PubMed ID: 33735479
[TBL] [Abstract][Full Text] [Related]
26. Optical coherence tomography measures correlate with brain and spinal cord atrophy and multiple sclerosis disease-related disability.
Vidal-Jordana A; Pareto D; Cabello S; Alberich M; Rio J; Tintore M; Auger C; Montalban X; Rovira A; Sastre-Garriga J
Eur J Neurol; 2020 Nov; 27(11):2225-2232. PubMed ID: 32602573
[TBL] [Abstract][Full Text] [Related]
27. Predictors of retinal atrophy in multiple sclerosis: A longitudinal study using spectral domain optical coherence tomography with segmentation analysis.
Behbehani R; Adnan H; Al-Hassan AA; Al-Salahat A; Alroughani R
Mult Scler Relat Disord; 2018 Apr; 21():56-62. PubMed ID: 29459346
[TBL] [Abstract][Full Text] [Related]
28. Retinal nerve fiber layer thickness associates with cognitive impairment and physical disability in multiple sclerosis.
Birkeldh U; Manouchehrinia A; Hietala MA; Hillert J; Olsson T; Piehl F; Kockum I; Brundin L; Zahavi O; Wahlberg-Ramsay M; Brautaset R; Nilsson M
Mult Scler Relat Disord; 2019 Nov; 36():101414. PubMed ID: 31574404
[TBL] [Abstract][Full Text] [Related]
29. Inner Retinal Layer Changes Reflect Changes in Ambulation Score in Patients with Primary Progressive Multiple Sclerosis.
Gernert JA; Böhm L; Starck M; Buchka S; Kümpfel T; Kleiter I; Havla J
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629053
[TBL] [Abstract][Full Text] [Related]
30. Retinal Nerve Fiber Layer Thickness Correlates with Serum and Cerebrospinal Fluid Neurofilament Levels and is Associated with Current Disability in Multiple Sclerosis.
Uzunköprü C; Yüceyar N; Yilmaz SG; Afrashi F; Ekmekçi Ö; Taşkiran D
Noro Psikiyatr Ars; 2021 Mar; 58(1):34-40. PubMed ID: 33795950
[TBL] [Abstract][Full Text] [Related]
31. Association of Serum Neurofilament Light Chain With Inner Retinal Layer Thinning in Multiple Sclerosis.
Sotirchos ES; Vasileiou ES; Filippatou AG; Fitzgerald KC; Smith MD; Lord HN; Kalaitzidis G; Lambe J; Duval A; Prince JL; Mowry EM; Saidha S; Calabresi PA
Neurology; 2022 Aug; 99(7):e688-e697. PubMed ID: 35618438
[TBL] [Abstract][Full Text] [Related]
32. Measurement of the Inner Retinal Layers of Megalopapilla by Optical Coherence Tomography.
Gama R; Relha C; Gomes Costa J; Eiro N
Med Hypothesis Discov Innov Ophthalmol; 2017; 6(3):82-88. PubMed ID: 29392147
[TBL] [Abstract][Full Text] [Related]
33. Thickness of macular inner retinal layers and peripapillary retinal nerve fibre layer in neuromyelitis optica spectrum optic neuritis and isolated optic neuritis with one episode.
Peng C; Wang W; Xu Q; Yang M; Zhou H; Zhao S; Wei S
Acta Ophthalmol; 2017 Sep; 95(6):583-590. PubMed ID: 27775238
[TBL] [Abstract][Full Text] [Related]
34. Optical coherence tomography assessment of axonal and neuronal damage of the retina in patients with familial and sporadic multiple sclerosis.
Grudziecka Pyrek M; Selmaj K
Front Neurol; 2022; 13():953188. PubMed ID: 36188381
[TBL] [Abstract][Full Text] [Related]
35. Individual Prognostication of Disease Activity and Disability Worsening in Multiple Sclerosis With Retinal Layer Thickness
Lin TY; Motamedi S; Asseyer S; Chien C; Saidha S; Calabresi PA; Fitzgerald KC; Samadzadeh S; Villoslada P; Llufriu S; Green AJ; Preiningerova JL; Petzold A; Leocani L; Garcia-Martin E; Oreja-Guevara C; Outteryck O; Vermersch P; Balcer LJ; Kenney R; Albrecht P; Aktas O; Costello F; Frederiksen J; Uccelli A; Cellerino M; Frohman EM; Frohman TC; Bellmann-Strobl J; Schmitz-Hübsch T; Ruprecht K; Brandt AU; Zimmermann HG; Paul F
Neurol Neuroimmunol Neuroinflamm; 2024 Sep; 11(5):e200269. PubMed ID: 38941572
[TBL] [Abstract][Full Text] [Related]
36. Predicting visual outcomes after decompression of pituitary tumours based on stratified inner-retinal layer thickness and age.
Lee GI; Park KA; Lee D; Oh SY; Kong DS; Hong SD
Acta Ophthalmol; 2023 May; 101(3):301-309. PubMed ID: 36398459
[TBL] [Abstract][Full Text] [Related]
37. Retinal layer thinning as a biomarker of long-term disability progression in multiple sclerosis.
Berek K; Hegen H; Hocher J; Auer M; Di Pauli F; Krajnc N; Angermann R; Barket R; Zinganell A; Riedl K; Deisenhammer F; Berger T; Bsteh G
Mult Scler; 2022 Oct; 28(12):1871-1880. PubMed ID: 35652366
[TBL] [Abstract][Full Text] [Related]
38. Optical coherence tomography as a prognostic tool for disability progression in MS: a systematic review.
Swinnen S; De Wit D; Van Cleemput L; Cassiman C; Dubois B
J Neurol; 2023 Feb; 270(2):1178-1186. PubMed ID: 36372866
[TBL] [Abstract][Full Text] [Related]
39. Retinal layer thinning is reflecting disability progression independent of relapse activity in multiple sclerosis.
Bsteh G; Hegen H; Altmann P; Auer M; Berek K; Pauli FD; Wurth S; Zinganell A; Rommer P; Deisenhammer F; Leutmezer F; Berger T
Mult Scler J Exp Transl Clin; 2020; 6(4):2055217320966344. PubMed ID: 33194221
[TBL] [Abstract][Full Text] [Related]
40. Subclinical neurodegeneration in multiple sclerosis and neuromyelitis optica spectrum disorder revealed by optical coherence tomography.
Pisa M; Ratti F; Vabanesi M; Radaelli M; Guerrieri S; Moiola L; Martinelli V; Comi G; Leocani L
Mult Scler; 2020 Sep; 26(10):1197-1206. PubMed ID: 31392924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
